Patient Registry Software Market by Type of Registry (Diabetes, Cancer, Rare Disease, Asthma, Kidney), Software (Integrated and Standalone), Delivery (On Premise and Cloud), Pricing Model, Database (Public), End User (Hospitals) - Global Forecast to 2026
The global patient registry software market in terms of revenue was estimated to be worth $1.4 billion in 2021 and is poised to reach $2.8 billion by 2026, growing at a CAGR of 15.0% from 2021 to 2026. Growth of this market is mainly attributed to the shift toward computerized registries to provide users with an automated way to store data and create, sort, and display patient lists for use in planning, quality improvement, reporting, and direct care delivery. Additionally, government initiatives to build patient registries, rising pressure to improve the quality of care and reduce healthcare cost, and rising adoption of EHRs and other eHealth solutions are also the key factors driving the market growth. Vendors are using organic growth strategies such as product launches and innovations, which has resulted into an increasing availability of advanced products globally.
To know about the assumptions considered for the study, Request for Free Sample Report
Patient Registry Software Market Dynamics
Drivers: Government initiatives to build patient registries
With the growing demand for population health management and health information exchange, government bodies across the globe are taking initiatives to digitize and integrate healthcare systems, including the development of computerized disease registries.
In the US, federal agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Centers for Medicare & Medicaid Services (CMS), Agency for Healthcare Research and Quality (AHRQ), Food and Drug Administration (FDA), and Agency for Toxic Substance and Disease Registry (ATSDR) along with several state agencies, are focusing on developing patient registries to determine the long-term outcomes of agents, devices, groups of drugs, or procedures.
Opportunities: High adoption rate of the subscription model
The subscription model requires minimal upfront investment and reduces the burden on healthcare systems since no IT staff is required. This results in increased productivity and cost-efficiency. This model also allows vendors to develop new and creative licensing models to reach prospects and customers in new ways. Healthcare providers are increasingly adopting software with subscription models, as it enables reduced time-to-value for any new features implemented in the software (they can also use it for a short period, as per their requirements). Currently, several market players are promoting the subscription model, as it offers a better scope to build trust and understand the requirements of healthcare providers (which, in turn, would help improve customer satisfaction). These advantages are expected to offer potential growth opportunities to market players during the forecast period.
Restrains: Privacy and data security-related concerns
Concerns related to data privacy and security are affecting the adoption of patient registry solutions among healthcare organizations, as the breach of a data registry can potentially expose confidential information of a large number of patients. In recent years, there has been significant growth in the number of healthcare data breaches. In healthcare, approximately one-third of data breaches result in medical identity theft, mainly due to a lack of internal control over patient information, outdated policies and procedures or non-adherence to existing ones, and inadequate personnel training. In the US, the Identity Theft Resource Center recorded 1,473 breaches in its 2019 breach list, an increase of 17% over the total number of breaches tracked in 2018. The healthcare sector alone accounted for 35.5% of the total tracked breaches. Such risk factors may hamper the market to a certain extent.
Challenges: Lack of awareness
Currently, the awareness about patient registries and the available solutions to make comprehensive patient registries is low among several stakeholders in the healthcare industry, especially in developing and underdeveloped countries. In developed countries, which have advanced healthcare infrastructure and high penetration of EHR solutions, the effects of this challenge are minimal. However, with HCIT adoption in the nascent stage in several developing and underdeveloped countries, a large number of healthcare providers, payers, and government and non-government organizations are unaware of the available HCIT solutions in the market, including patient registry software. This challenge can be overcome through initiatives such as seminars, symposiums, workshops, and training sessions focusing on increasing awareness about the functionalities of patient registry software and developing a skilled workforce with the relevant knowledge to effectively use these solutions.
Disease registries dominates the patient registry software market in 2020
Disease registries include information about patients diagnosed with a specific disease. The large share of disease registry segment can be attributed to the increase in the aging population, rising prevalence of chronic and rare & new diseases, growing awareness on the role of registries in health management, and the adoption of EHRs across the globe. The value of disease registries is increasingly being recognized as they provide historically comparable data and long-term evaluation, potentially serving as an addition to randomized clinical trials and thus providing insights about real-site outcomes that limited controlled studies do not address. Additionally, increasing government initiatives to develop and maintain patient health records (to reduce healthcare costs) and the growing awareness about collecting and utilizing patient health information are driving the adoption of disease registries.
Patient care management is expected to register the highest growth rate during the forecast period
The high growth rate of patient care management can be attributed to government initiatives to boost the adoption of patient registry software by hospitals & medical practices. Patient registry software for patient care management offers numerous advantages such as patient monitoring, care reminders, automated patient outreach, quality reporting, care gap identification, physician performance evaluation, and service cost-efficiency. To improve patient care management, healthcare organizations are increasingly adopting patient registries to improve patient care quality and provide appropriate care through a brief study of patient’s histories.
Government Organizations & TPAs are the largest end users of patient registry software
The large share of this segment can be attributed to the emergence of the COVID-19 pandemic and the need for analyzing patient data for better population health management. Patient registry software helps government organizations to evaluate the outcomes of specific disease-conditioned patients. Based on data outcomes, governments can benchmark and standardize the treatment process for a particular patient population, analyze disease patterns/trends, and take appropriate preventive measures. Currently, governments and government organizations across the globe are focusing on building patient registries to use observational study data rather than experimental study data received through random drug trials.
Asia Pacific is expected to witness the highest growth rate during the forecast period
Market growth in the Asia Pacific region is mainly driven by the increasing incidence of chronic diseases, rising awareness about the benefits of EHRs, improvements in healthcare systems, the development of medical tourism in Asian countries, and high demand for EHRs in Asian countries. The adoption of innovative technologies is increasing in Asia Pacific. In this region, disease registries are a prime focus area, while medical devices and other product registries are comparatively underdeveloped. The region shows a very high demand for EHRs due to its rising geriatric population and prevalence of chronic conditions.
To know about the assumptions considered for the study, download the pdf brochure
The prominent players in this market are IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), Premier, Inc. (US), ArborMetrix (US), FIGmd (US), McKesson Corporation (US), Syneos Health (US), Dacima Software (Canada), ifa Systems AG (Germany), Medstreaming- M2S (US), ImageTrend (US), Evado Clinical (Australia) and WIRB Copernicus Group (US), Global Vision Technologies (US), Conduent, Inc. (US), Elekta AB (Sweden), Cedaron (US), Lumdex (US), Armus (US), Phamax AG (Switzerland), and Versaform Systems Corp (US), ESO Solutions (US) and Ordinal Data Inc. (US).
Patient Registry Software Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$1.4 billion |
|
Estimated Value by 2026 |
$2.8 billion |
|
Growth Rate |
Poised to grow at a CAGR of 15.0% |
|
Largest Share Segments |
|
|
Market Report Segmentation |
Types of Registry, Software, Delivery, Pricing Model, Database, End User |
|
Growth Drivers |
|
|
Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
Patient Registry Software Market Report Segmentation
By Types of Registry
-
- Introduction
-
Disease Registry
- Diabetes Registries
- Cardiovascular Registries
- Cancer Registries
- Rare Disease Registries
- Asthma Registries
- Chronic Kidney Registries
- Orthopedic Registries
- Other Disease Registries
- Health Service Registeries
-
Product Registeries
- Medical Device Registries
- Drug Registries
By Type of Software
-
- Introduction
- Integrated Software
By Pricing Model
-
- Introduction
- Subscription Model;
- Ownership Model
By Deployment Model
-
- Introduction
- On-Premise Model
- Cloud-Based Model
By Type of Database
-
- Introduction
- Commercial Database
- Public Database
By Functionality
-
- Introduction
- Population Health Management
- Patient Care Management
- Medical Research & Clinical Studies
- Health Information Exchange
- Point-of-Care
- Product Outcome Evaluation
By End User
-
- Introduction
- Government Organizations and Third-Party Administrators;
- Hospitals & Medical Practices
- Private Payers
- Pharmaceutical, Biotechnology, and Medical Device Companies
- Research Centers
By Region
-
North America
- US
- Canada
-
Europe
- Uk
- Germany
- France
- Italy
- Spain
- Rest Of Europe
-
Asia Pacific
- Japan
- China
- India
- Rest of APAC
- Latin America
- Middle East & Africa
Recent Developments:
- In March 2021, ESO Solutions (US) entered into a partnership with Virginia EMS Systems (US) to deliver a statewide EMS data repository and statewide trauma registry for the collection and analysis of data to reveal key insights and trends.
- In December 2020, ImageTrend, Inc. (US) announced the latest National Trauma Data Bank (NTDB) Data Dictionary will be available in Patient Registry on January 1, 2021.
- In November 2020, ArborMetrix, Inc. (US) entered into a partnership with the American Academy of Pediatrics to develop and grow a clinical registry to advance all children's health, well-being, and development.
- In October 2020, Dacima Software, Inc. (Canada) with Movember (Australia) to design and develop a new registry database to launch the world's largest prostate cancer patient registry network.
- In June 2020, ArborMetrix Inc. (US) entered into a partnership with The Society of Interventional Radiology (SIR) (US). This partnership aims to provide the IR Quality Registry to improve patient care by integrating analytics.
Frequently Asked Questions (FAQs):
What is the size of Patient Registry Software Market?
The global patient registry software market crossed $1.4 billion in 2021, and is poised to grow at a CAGR of 15.0% in the next five years to reach $2.8 billion.
Why is Patient Registry Software Market Growing?
Patient registry software is growing in popularity because it allows for better tracking of patient data, improved communication between healthcare providers and patients, and increased efficiency in the healthcare system. Additionally, patient registry software is becoming more widely used as a means to reduce costs and improve healthcare quality. The ability to more accurately measure patient outcomes and monitor treatment patterns is also driving the growth of registry software. Finally, the ability to quickly share patient data across various settings, such as hospitals, clinics, and pharmacies, is making the software invaluable in improving patient safety and reducing wait times.
Who all are the prominent players of Patient Registry Software Market?
The prominent players in this market are IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), Premier, Inc. (US), ArborMetrix (US), FIGmd (US), McKesson Corporation (US), Syneos Health (US), Dacima Software (Canada), ifa Systems AG (Germany), Medstreaming- M2S (US), ImageTrend (US), Evado Clinical (Australia) and WIRB Copernicus Group (US), Global Vision Technologies (US), Conduent, Inc. (US), Elekta AB (Sweden), Cedaron (US), Lumdex (US), Armus (US), Phamax AG (Switzerland), and Versaform Systems Corp (US), ESO Solutions (US) and Ordinal Data Inc. (US).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 37)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 PATIENT REGISTRY SOFTWARE MARKET
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES USED FOR CONVERSION TO USD
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 42)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE PATIENT REGISTRY SOFTWARE MARKET (2021-2026)
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 8 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: PATIENT REGISTRY SOFTWARE MARKET
3 EXECUTIVE SUMMARY (Page No. - 54)
FIGURE 9 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2021 VS. 2026 (USD MILLION)
FIGURE 10 PATIENT REGISTRY MARKET, BY TYPE OF SOFTWARE, 2021 VS. 2026 (USD MILLION)
FIGURE 11 MARKET, BY PRICING MODEL, 2021 VS. 2026 (USD MILLION)
FIGURE 12 MARKET, BY DEPLOYMENT MODEL, 2021 VS. 2026 (USD MILLION)
FIGURE 13 MARKET, BY TYPE OF DATABASE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 MARKET, BY FUNCTIONALITY, 2021 VS. 2026 (USD MILLION)
FIGURE 15 MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF PATIENT REGISTRY SOFTWARE MARKET
4 PREMIUM INSIGHTS (Page No. - 62)
4.1 PATIENT REGISTRY SOFTWARE MARKET OVERVIEW
FIGURE 17 RISING ADOPTION OF ELECTRONIC HEALTH RECORDS AND OTHER E-HEALTH SOLUTIONS DRIVING MARKET
4.2 ASIA PACIFIC: PATIENT REGISTRY MARKET, BY TYPE OF REGISTRY AND COUNTRY (2020)
FIGURE 18 DISEASE REGISTRIES SEGMENT AND JAPAN ACCOUNTED FOR LARGEST SHARES
4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 REGIONAL MIX: MARKET (2021−2026)
FIGURE 20 NORTH AMERICA TO DOMINATE MARKET IN 2026
4.5 PATIENT REGISTRY MARKET: DEVELOPING VS. DEVELOPED MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 67)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Government initiatives to build patient registries
5.2.1.2 Rising pressure to improve quality of care and reduce healthcare costs
5.2.1.3 Rising adoption of EHRs and other eHealth solutions
5.2.1.4 Growing patient volume due to global outbreak of COVID-19
5.2.1.5 Growing use of patient registry data for post-marketing surveillance
5.2.2 MARKET RESTRAINTS
5.2.2.1 Privacy- and data security-related concerns
5.2.2.2 Shortage of trained and skilled resources
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Rising number of accountable care organizations
5.2.3.2 Emergence of cloud-based patient registry solutions
5.2.3.3 High adoption rate of subscription model
5.2.4 MARKET CHALLENGES
5.2.4.1 Lack of interoperability and integration
5.2.4.2 Reluctance to adopt advanced solutions
5.2.4.3 Lack of awareness
5.3 REGULATORY ANALYSIS
TABLE 3 KEY REGULATIONS & STANDARDS GOVERNING MEDICAL DEVICE CONNECTIVITY SOLUTIONS
5.3.1 INTEROPERABILITY STANDARDS
TABLE 4 KEY STANDARDS FOR INTEROPERABILITY IN DIGITAL HEALTH SPECTRUM
TABLE 5 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN DIGITAL HEALTH SPECTRUM
5.4 PRICING ANALYSIS
5.5 TECHNOLOGY ANALYSIS
5.6 ECOSYSTEM ANALYSIS
FIGURE 23 ECOSYSTEM ANALYSIS: PATIENT REGISTRY SOFTWARE MARKET
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR PATIENT REGISTRY SOFTWARE
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2021)
5.7.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 25 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR PATIENT REGISTRIES PATENTS (JANUARY 2011 TO JUNE 2021)
FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT REGISTRY SOFTWARE PATENTS (JANUARY 2011 TO JUNE 2021)
6 INDUSTRY INSIGHTS (Page No. - 82)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 SHIFTING FOCUS TOWARD PATIENT-POWERED RESEARCH NETWORKS
6.2.2 GROWING DEVELOPMENTS IN AUTOMATED DATA ENTRIES
6.3 IMPACT OF COVID-19 ON PATIENT REGISTRY MARKET
7 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY (Page No. - 84)
7.1 INTRODUCTION
TABLE 6 MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 7 MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2 DISEASE REGISTRIES
TABLE 8 DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 9 DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 DIABETES REGISTRIES
7.2.1.1 Growing obese and geriatric populations to drive market growth
TABLE 10 DIABETES REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 11 DIABETES REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 CARDIOVASCULAR REGISTRIES
7.2.2.1 Rising prevalence of heart diseases and strokes worldwide to drive market growth
TABLE 12 CARDIOVASCULAR REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 13 CARDIOVASCULAR REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 CANCER REGISTRIES
7.2.3.1 Increasing need to manage growing number of cancer patients to propel market growth
TABLE 14 CANCER REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 15 CANCER REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 RARE DISEASE REGISTRIES
7.2.4.1 Increasing funding for research on rare diseases and their treatments to boost market growth
TABLE 16 RARE DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 17 RARE DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 ASTHMA REGISTRIES
7.2.5.1 Increasing prevalence of asthma significantly driving market growth
TABLE 18 ASTHMA REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 19 ASTHMA REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.6 CHRONIC KIDNEY DISEASE REGISTRIES
7.2.6.1 Rising prevalence of chronic kidney diseases to drive market growth
TABLE 20 CHRONIC KIDNEY DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 21 CHRONIC KIDNEY DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.7 ORTHOPEDIC REGISTRIES
7.2.7.1 Growing number of patients suffering from orthopedic diseases to drive market growth
TABLE 22 ORTHOPEDIC REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 23 ORTHOPEDIC REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.8 OTHER DISEASE REGISTRIES
TABLE 24 OTHER DISEASE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 HEALTH SERVICE REGISTRIES
7.3.1 CAPTURE SERVICE-GENERATED DATA DERIVED FROM HEALTH FACILITIES
TABLE 25 HEALTH SERVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 26 HEALTH SERVICE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 PRODUCT REGISTRIES
TABLE 27 PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 28 PRODUCT REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.1 MEDICAL DEVICE REGISTRIES
7.4.1.1 Strong government support and initiatives to drive demand for medical device registries
TABLE 29 MEDICAL DEVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 30 MEDICAL DEVICE REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4.2 DRUG REGISTRIES
7.4.2.1 Increasing post-marketing surveillance of drugs to drive market growth
TABLE 31 DRUGS REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 32 DRUG REGISTRIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE (Page No. - 106)
8.1 INTRODUCTION
TABLE 33 PATIENT REGISTRY MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
8.2 STANDALONE SOFTWARE
8.2.1 STANDALONE SOFTWARE TO DOMINATE MARKET IN FORECAST PERIOD
TABLE 34 STANDALONE SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 35 STANDALONE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 INTEGRATED SOFTWARE
8.3.1 INTEGRATED SOFTWARE SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
TABLE 36 INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 37 INTEGRATED MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL (Page No. - 111)
9.1 INTRODUCTION
TABLE 38 MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
9.2 SUBSCRIPTION MODEL
9.2.1 LOW COST OF SUBSCRIPTION MODELS TO SUPPORT SEGMENT GROWTH
TABLE 39 SUBSCRIPTION-BASED PATIENT REGISTRY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 OWNERSHIP MODEL
9.3.1 RISING ADOPTION OF INTEGRATED SOFTWARE MODEL TO SUPPORT SEGMENT GROWTH
TABLE 40 OWNERSHIP-BASED MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
10 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL (Page No. - 115)
10.1 INTRODUCTION
TABLE 41 MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
10.2 ON-PREMISE MODEL
10.2.1 ON-PREMISE SOLUTIONS REDUCE RISK OF DATA BREACHES AND OTHER SECURITY ISSUES
TABLE 42 ON-PREMISE PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 43 ON-PREMISE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
10.3 CLOUD-BASED MODEL
10.3.1 CLOUD-BASED SOLUTIONS HELP HEALTHCARE ORGANIZATIONS SHARE AND INTEGRATE INFORMATION FROM DISPARATE LOCATIONS IN REAL-TIME
TABLE 44 CLOUD-BASED PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 45 CLOUD-BASED PATIENT REGISTRY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
11 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE (Page No. - 121)
11.1 INTRODUCTION
TABLE 46 PATIENT REGISTRY MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
11.2 COMMERCIAL DATABASES
11.2.1 COMMERCIAL REGISTRIES ARE GENERALLY PRIVATELY FUNDED OR INDUSTRY-SPONSORED
TABLE 47 PATIENT REGISTRY SOFTWARE FOR COMMERCIAL DATABASES OFFERED BY KEY MARKET PLAYERS
TABLE 48 MARKET FOR COMMERCIAL DATABASES, BY COUNTRY, 2019–2026 (USD MILLION)
11.3 PUBLIC DATABASES
11.3.1 PUBLIC REGISTRIES ARE FUNDED BY FEDERAL, STATE, OR LOCAL GOVERNMENT AGENCIES
TABLE 49 PATIENT REGISTRY SOFTWARE FOR PUBLIC DATABASES OFFERED BY KEY MARKET PLAYERS
TABLE 50 MARKET FOR PUBLIC DATABASES, BY COUNTRY, 2019–2026 (USD MILLION)
12 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY (Page No. - 126)
12.1 INTRODUCTION
TABLE 51 PATIENT REGISTRY MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
12.2 POPULATION HEALTH MANAGEMENT
12.2.1 INCREASING DEMAND FOR QUALITY CARE DRIVES ADOPTION OF PHM SOLUTIONS
TABLE 52 MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION)
12.3 PATIENT CARE MANAGEMENT
12.3.1 GOVERNMENT INITIATIVES AND REGULATIONS PROMOTING PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH
TABLE 53 MARKET FOR PATIENT CARE MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION)
12.4 MEDICAL RESEARCH & CLINICAL STUDIES
12.4.1 CONTINUOUS RESEARCH FOR COVID-19 VACCINE SUPPORTING SEGMENT GROWTH
TABLE 54 MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY COUNTRY, 2019–2026 (USD MILLION)
12.5 HEALTH INFORMATION EXCHANGE
12.5.1 INCREASING NEED FOR SHARING OF VITAL PATIENT INFORMATION WITH CARE PROVIDERS SUPPORTS ADOPTION OF SOLUTIONS
TABLE 55 PATIENT REGISTRY MARKET FOR HEALTH INFORMATION EXCHANGE, BY COUNTRY, 2019–2026 (USD MILLION)
12.6 POINT OF CARE
12.6.1 URGENT NEED FOR STREAMLINED PATIENT CARE PROCESS TO DRIVE GROWTH
TABLE 56 MARKET FOR POINT OF CARE, BY COUNTRY, 2019–2026 (USD MILLION)
12.7 PRODUCT OUTCOME EVALUATION
12.7.1 INCREASING POST-MARKETING SURVEILLANCE IN BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES TO PROPEL MARKET GROWTH
TABLE 57 MARKET FOR PRODUCT OUTCOME EVALUATION, BY COUNTRY, 2019–2026 (USD MILLION)
13 PATIENT REGISTRY SOFTWARE MARKET, BY END-USER (Page No. - 136)
13.1 INTRODUCTION
TABLE 58 MARKET, BY END USER, 2019–2026 (USD MILLION)
13.2 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS
13.2.1 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS HOLD LARGEST SHARE IN END-USER MARKET
TABLE 59 MARKET FOR GOVERNMENT ORGANIZATIONS & TPAS, BY COUNTRY, 2019–2026 (USD MILLION)
13.3 HOSPITALS & MEDICAL PRACTICES
13.3.1 DEMAND FOR REGISTRY SOFTWARE SUPPORTED BY A GROWING FOCUS ON PATIENT SAFETY AND IMPROVING PATIENT OUTCOMES
TABLE 60 MARKET FOR HOSPITALS & MEDICAL PRACTICES, BY COUNTRY, 2019–2026 (USD MILLION)
13.4 PRIVATE PAYERS
13.4.1 NEED TO CURB RISING HEALTHCARE COSTS TO DRIVE MARKET GROWTH
TABLE 61 MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2019–2026 (USD MILLION)
13.5 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES
13.5.1 EVOLVING REGULATORY GUIDELINES ON PATIENT SAFETY BY REGULATORY BODIES TO PROPEL SEGMENT GROWTH
TABLE 62 MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
13.6 RESEARCH CENTERS
13.6.1 INCREASED CLINICAL TRIALS & RESEARCH ON DISEASE TREATMENT SUPPORTS GROWTH
TABLE 63 MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2019–2026 (USD MILLION)
14 PATIENT REGISTRY SOFTWARE MARKET, BY REGION (Page No. - 144)
14.1 INTRODUCTION
FIGURE 27 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 64 PATIENT REGISTRY MARKET, BY REGION, 2019–2026 (USD MILLION)
14.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: PATIENT REGISTRY MARKET SNAPSHOT
TABLE 65 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 67 NORTH AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 NORTH AMERICA: DISEASE REGISTRIES MARKET, BY TYPE, –2026 (USD MILLION)
TABLE 69 NORTH AMERICA: MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 72 NORTH AMERICA: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: PATIENT REGISTRY MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: PATIENT REGISTRY MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.2.1 US
14.2.1.1 Largest market for patient registry software
TABLE 75 US: PATIENT REGISTRY MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 76 US: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 US: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 US: PATIENT REGISTRY MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 79 US: PATIENT REGISTRY MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 80 US: PATIENT REGISTRY MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 81 US: PATIENT REGISTRY MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 82 US: PATIENT REGISTRY MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 83 US: PATIENT REGISTRY MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.2.2 CANADA
14.2.2.1 Launch of new government initiatives is expected to drive the adoption of patient registry software across the country
TABLE 84 CANADA: PATIENT REGISTRY MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 85 CANADA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 CANADA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 CANADA: PATIENT REGISTRY MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 88 CANADA: PATIENT REGISTRY MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 89 CANADA: PATIENT REGISTRY MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 90 CANADA: PATIENT REGISTRY MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 91 CANADA: PATIENT REGISTRY MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 92 CANADA: PATIENT REGISTRY MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3 EUROPE
TABLE 93 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 94 EUROPE: PATIENT REGISTRY MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 95 EUROPE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 EUROPE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 EUROPE: PATIENT REGISTRY MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 98 EUROPE: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 99 EUROPE: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 100 EUROPE: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 101 EUROPE: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 102 EUROPE: MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.1 GERMANY
14.3.1.1 High healthcare spending to support adoption of patient registry software solutions
TABLE 103 GERMANY: PATIENT REGISTRY MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 104 GERMANY: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 GERMANY: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 106 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 107 GERMANY: PATIENT REGISTRY MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 108 GERMANY: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 109 GERMANY: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 110 GERMANY: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 111 GERMANY: MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.2 UK
14.3.2.1 Government initiatives to support market growth
TABLE 112 UK: PATIENT REGISTRY MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 113 UK: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 UK: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 UK: PATIENT REGISTRY MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 116 UK: MARKET, BY PRICING MODEL,2019–2026 (USD MILLION)
TABLE 117 UK: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 118 UK: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 119 UK: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 120 UK: MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.3 FRANCE
14.3.3.1 Large number of COVID-19 cases to support market growth
TABLE 121 FRANCE: PATIENT REGISTRY MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 122 FRANCE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 FRANCE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 FRANCE: PATIENT REGISTRY MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 125 FRANCE: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 126 FRANCE: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 127 FRANCE: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 128 FRANCE: PATIENT REGISTRY MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 129 FRANCE: PATIENT REGISTRY MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.4 ITALY
14.3.4.1 Rising prevalence of chronic diseases to increase demand for patient registry software
TABLE 130 ITALY: PATIENT REGISTRY MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 131 ITALY: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 ITALY: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 ITALY: PATIENT REGISTRY MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 134 ITALY: PATIENT REGISTRY MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 135 ITALY: PATIENT REGISTRY MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 136 ITALY: PATIENT REGISTRY MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 137 ITALY: MARKET, BY FUNCTIONALITY,2019–2026 (USD MILLION)
TABLE 138 ITALY: MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.5 SPAIN
14.3.5.1 Government initiatives to improve adoption of patient registry software and eHealth solutions to drive demand
TABLE 139 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 140 SPAIN: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 SPAIN: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 142 SPAIN: MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 143 SPAIN: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 144 SPAIN: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 145 SPAIN: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 146 SPAIN: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 147 SPAIN: MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.3.6 REST OF EUROPE
TABLE 148 ROE: MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 149 ROE: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 150 ROE: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 151 ROE: MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 152 ROE: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 153 ROE: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 154 ROE: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 155 ROE: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 156 ROE: MARKET, BY END-USER, 2019–2026 (USD MILLION)
14.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 157 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 158 ASIA PACIFIC: MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 159 ASIA PACIFIC: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 ASIA PACIFIC: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 ASIA PACIFIC: MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 162 ASIA PACIFIC: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 163 ASIA PACIFIC: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 164 ASIA PACIFIC: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 165 ASIA PACIFIC: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 166 ASIA PACIFIC: MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.1 JAPAN
14.4.1.1 Highest adoption rates of EMR and patient registry software solutions
TABLE 167 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 168 JAPAN: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 JAPAN: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 170 JAPAN: MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 171 JAPAN: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 172 JAPAN: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 173 JAPAN: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 174 JAPAN: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 175 JAPAN: MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.2 CHINA
14.4.2.1 Absence of a patient-centered model may challenge adoption of patient registry software
TABLE 176 CHINA: MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 177 CHINA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 CHINA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 179 CHINA: MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 180 CHINA: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 181 CHINA: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 182 CHINA: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 183 CHINA: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 184 CHINA: MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.3 INDIA
14.4.3.1 One of the lucrative markets in eHealth field
TABLE 185 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 186 INDIA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 187 INDIA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 188 INDIA: MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 189 INDIA: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 190 INDIA: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 191 INDIA: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 192 INDIA: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 193 INDIA: MARKET, BY END USER, 2019–2026 (USD MILLION)
14.4.4 REST OF ASIA PACIFIC
TABLE 194 ROAPAC: MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 195 ROAPAC: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 196 ROAPAC: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 197 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 198 ROAPAC: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 199 ROAPAC: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 200 ROAPAC: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 201 ROAPAC: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 202 ROAPAC: MARKET, BY END USER, 2019–2026 (USD MILLION)
14.5 LATIN AMERICA
14.5.1 LOW ADOPTION RATE OF EHR SOLUTIONS
TABLE 203 LATIN AMERICA: MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 204 LATIN AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 205 LATIN AMERICA: DISEASE REGISTRIES MARKET, BY TYPE,2019–2026 (USD MILLION)
TABLE 206 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 207 LATIN AMERICA: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 208 LATIN AMERICA: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 209 LATIN AMERICA: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 210 LATIN AMERICA: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 211 LATIN AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
14.6 MIDDLE EAST & AFRICA
14.6.1 GROWING GOVERNMENT INVESTMENTS DRIVING ADOPTION OF PATIENT REGISTRIES
TABLE 212 MIDDLE EAST & AFRICA: MARKET, BY TYPE OF REGISTRY, 2019–2026 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: DISEASE REGISTRIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: MARKET, BY TYPE OF SOFTWARE, 2019–2026 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: MARKET, BY PRICING MODEL, 2019–2026 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: MARKET, BY DEPLOYMENT MODEL, 2019–2026 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: MARKET, BY TYPE OF DATABASE, 2019–2026 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: MARKET, BY FUNCTIONALITY, 2019–2026 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
15 COMPETITIVE LANDSCAPE (Page No. - 222)
15.1 OVERVIEW
FIGURE 30 KEY PLAYER STRATEGIES
15.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 31 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET
15.3 MARKET SHARE ANALYSIS
FIGURE 32 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
15.4 COMPETITIVE LEADERSHIP MAPPING
15.4.1 STARS
15.4.2 EMERGING LEADERS
15.4.3 PERVASIVE PLAYERS
15.4.4 PARTICIPANTS
FIGURE 33 MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
15.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS
15.5.1 PROGRESSIVE COMPANIES
15.5.2 DYNAMIC COMPANIES
15.5.3 STARTING BLOCKS
15.5.4 RESPONSIVE COMPANIES
FIGURE 34 PATIENT REGISTRY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020)
15.6 COMPETITIVE SCENARIO
15.6.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 221 PRODUCT LAUNCHES & APPROVALS
15.6.2 DEALS
TABLE 222 DEALS (2018–2021)
15.7 COMPETITIVE BENCHMARKING
FIGURE 35 FOOTPRINTS OF COMPANY IN PATIENT REGISTRY SOFTWARE MARKET
TABLE 223 COMPANY BY TYPE OF REGISTRY FOOTPRINT (25 COMPANIES)
TABLE 224 COMPANY BY REGIONAL FOOTPRINT (25 COMPANIES)
16 COMPANY PROFILES (Page No. - 235)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1 IBM CORPORATION
FIGURE 36 IBM: COMPANY SNAPSHOT (2020)
16.2 IQVIA HOLDINGS
FIGURE 37 IQVIA HOLDINGS: COMPANY SNAPSHOT (2020)
16.3 OPENTEXT CORPORATION
FIGURE 38 OPENTEXT CORPORATION: COMPANY SNAPSHOT (2020)
16.4 OPTUM
FIGURE 39 OPTUM: COMPANY SNAPSHOT (2020)
16.5 PREMIER INC.
FIGURE 40 PREMIER: COMPANY SNAPSHOT
16.6 SYNEOS HEALTH
FIGURE 41 SYNEOS HEALTH: COMPANY SNAPSHOT (2020)
16.7 FIGMD
16.8 IMAGETREND, INC.
16.9 DACIMA SOFTWARE, INC.
16.10 GLOBAL VISION TECHNOLOGIES, INC.
16.11 IFA SYSTEMS AG
FIGURE 42 IFA SYSTEMS AG: COMPANY SNAPSHOT (2020)
16.12 MEDSTREAMING- M2S
16.13 MCKESSON CORPORATION
FIGURE 43 MCKESSON CORPORATION: COMPANY SNAPSHOT (2020)
16.14 EVADO CLINICAL
16.15 WIRB COPERNICUS GROUP
16.16 ARBORMETRIX, INC.
16.17 CONDUENT, INC.
FIGURE 44 CONDUENT INC: COMPANY SNAPSHOT (2020)
16.18 ELEKTA AB
FIGURE 45 ELEKTA AB: COMPANY SNAPSHOT (2020)
16.19 ORDINAL DATA, INC.
16.2 ESO SOLUTIONS
16.21 LUMEDX
16.22 ARMUS CORP
16.23 CEDARON
16.24 PHAMAX AG
16.25 VERSAFORM SYSTEMS CORP
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 APPENDIX (Page No. - 278)
17.1 INSIGHTS OF INDUSTRY EXPERTS
17.2 DISCUSSION GUIDE
17.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.4 AVAILABLE CUSTOMIZATIONS
17.5 RELATED REPORTS
17.6 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global patient registry software market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the market. The primary sources from the demand side include medical practitioners, hospital managers, CEOs, vice presidents, directors of operations and research in pharmaceutical companies, and research heads.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by types of registry, types of software, pricing model, deployment model, types of database, functionality, end user, and region).
Data Triangulation
After arriving at the market size, the total patient registry software market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To define, describe, segment, and forecast the patient registry software market types of registry, types of software, pricing model, deployment model, types of database, functionality, end user, and region
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the patient registry software market in five main regions (along with their respective key countries), namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile the key players in the market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions; new product launches; expansions; collaborations, agreements, and partnerships; and R&D activities of the leading players in the patient registry software market
- To benchmark players within the market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of registries and business strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific patient registry software market into Australia, New Zealand and others
- Further breakdown of the Rest of Europe patient registry software market into The Netherlands, Sweden, Norway and others
- Further breakdown of the Latin America patient registry software market into Brazil, Mexico, and others
Growth opportunities and latent adjacency in Patient Registry Software Market